Jonas A Schäfer (Jonas Schäfer)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Venues

Blood advances

Cancers

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf, Jonas B Vischedyk, Philipp Makowka, Julius C Enssle, Khouloud Kouidri, Martin Sebastian, Björn Steffen, Thomas Oellerich, Hubert Serve, Andreas Neubauer, Jonas A Schäfer, Jörg T Bittenbring
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy. European journal of haematology (2024)
Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh, Dries Deeren, Larisa Girshova, Jürgen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas A Schäfer, Oliver Gerhard Ottmann, Mario Petrini, Arnaud Pigneux, Alessandro Rambaldi, Christian Recher, Rebeca Rodriguez-Veiga, David Taussig, Norbert Vey, Sung Soo Yoon, Marion Ott, Susanne Muehlbauer, Benjamin M Beckermann, Olivier Catalani, Magali Genevray, Kirsten Mundt, Candice Jamois, Pierre Fenaux, Andrew H Wei
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial. Blood advances 6 (14) (2022)
Thomas S Tarawneh, Fiona R Rodepeter, Julia Teply-Szymanski, Petra Ross, Vera Koch, Clemens Thölken, Jonas A Schäfer, Niklas Gremke, Hildegard I D Mack, Judith Gold, Jorge Riera-Knorrenschild, Christian Wilhelm, Anja Rinke, Martin Middeke, Andreas Klemmer, Marcel Romey, Akira Hattesohl, Moritz Jesinghaus, Christian Görg, Jens Figiel, Ho-Ryun Chung, Thomas Wündisch, Andreas Neubauer, Carsten Denkert, Elisabeth K M Mack
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board. Cancers 14 (18) (2022)
Marion Subklewe, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit L Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas A Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood advances 6 (16) (2022)

Jonas A Schäfer.css-eqlu8i{font-size:small;padding-left:4px;} (Jonas Schäfer)

Publication Activity (10 Years)

Top Topics

Top Venues

Jonas A Schäfer (Jonas Schäfer)